COVID-19 living evidence synthesis #6 (version 6.33): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?

Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN

Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/32084

Full metadata record

DC Field	Value	Language
dc.contributor.author	Iorio, A	-
dc.contributor.author	Little, J	-
dc.contributor.author	Linkins, L	-
dc.contributor.author	Abdelkader, W	-
dc.contributor.author	Bennett, D	-
dc.contributor.author	Lavis, JN	-
dc.date.accessioned	2025-07-31T21:02:15Z	-
dc.date.available	2025-07-31T21:02:15Z	-
dc.date.issued	2022-03	-
dc.identifier.citation	Iorio A, Little J, Linkins L, Abdelkader W, Bennett D, Lavis JN. COVID-19 living evidence synthesis #6 (version 6.33): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? Health Information Research Unit (HIRU); McMaster and Ottawa Knowledge Synthesis and Application Unit, 30 March 2022.	en_US
dc.identifier.uri	http://hdl.handle.net/11375/32084	-
dc.description.abstract	An in-depth synthesis of what is known, based on the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies), about the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern.	en_US
dc.description.sponsorship	The development and continued updating of this living evidence synthesis has been funded by the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada.	en_US
dc.language.iso	en	en_US
dc.relation.ispartofseries	LES 6.33;	-
dc.subject	efficacy	en_US
dc.subject	effectiveness	en_US
dc.subject	COVID-19	en_US
dc.subject	vaccines	en_US
dc.subject	variants	en_US
dc.title	COVID-19 living evidence synthesis #6 (version 6.33): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?	en_US
Appears in Collections:	Living evidence synthesis

Files in This Item:

File	Description	Size	Format
COVID-19 Living Evidence Synthesis 6.33 - What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern.pdf Open Access		1.11 MB	Adobe PDF	View/Open

Show simple item record

This item is licensed under a Creative Commons License